Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. OPRX

Market Cap: $136.8M

OC

OptimizeRx Corp.

OPRX
NASDAQUSD
Purchase OPRX
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin72.14%
EBITDA Margin15.82%
EBIT Margin11.61%
Pre-tax Margin6.87%
Net Profit Margin4.66%
Earnings Yield3.36%
Valuation Multiples
Price / Book1.04
Price / Sales1.39
Price / Earnings29.93
PEG0.00
Forward PEG1.45
EV / Sales1.34
EV / EBITDA8.47
EV / Operating Cash Flow7.17
EV / Free Cash Flow7.20
Price / Free Cash Flow7.45
Price / Operating Cash Flow7.43
Cash Flow & Capital
Free Cash Flow / Share$0.98
Operating Cash Flow / Share$0.98
Free Cash Flow Yield13.42%
Capex / Revenue0.08%
Capex / Operating Cash Flow0.42%
Capex / Depreciation0.02
Stock Compensation / Revenue8.06%
Dividend Payout Ratio0.00%
Dividend Yield0.00%
Liquidity & Leverage
Current Ratio5.58
Quick Ratio5.58
Cash Ratio2.48
Debt / Assets0.12
Debt / Capital0.13
Debt / Equity0.15
Long-Term Debt / Capital0.12
Debt / Market Cap13.89%
Net Debt / EBITDA-0.30
Solvency Ratio0.26
Financial Leverage1.25
Efficiency & Working Capital
Asset Turnover0.60
Fixed Asset Turnover171.87
Inventory Turnover0.00
Receivables Turnover3.64
Payables Turnover20.77
Days Sales Outstanding100.35
Days Inventory Outstanding0
Days Payables Outstanding17.57
Operating Cycle100.35
Cash Conversion Cycle82.78
Working Capital Turnover2.19
Returns & Quality
Return on Equity3.60%
Return on Assets2.80%
Return on Invested Capital4.91%
ROCE7.31%
Return on Tangible Assets7.54%
Operating Return on Assets6.81%
Income Quality4.01
Tax Burden0.68
Interest Burden0.59
Balance Sheet & Intrinsic Metrics
Enterprise Value$132.18M
Invested Capital$148.31M
Working Capital$44.44M
Tangible Asset Value$27.78M
Net Current Asset Value$20.91M
Graham Number$6.2
Graham Net-Net$0.6
Book Value / Share$6.98
Tangible Book Value / Share$1.48
Cash / Share$1.28
Financial Health Scores
Piotroski Score7
Altman Z-Score2.91
Revenue$98.65M
EBIT$11.46M
Market Cap$135.39M
Working Capital$44.44M
Retained Earnings$-80.43M
Total Assets$164.32M
Total Liabilities$33.24M